德诺苏马布
医学
钙
内科学
肿瘤科
癌症
骨质疏松症
作者
Hiroaki Ikesue,Toshikazu Tsuji,Koujiro Hata,Hiroyuki Watanabe,Kazuto Mishima,Mayako Uchida,Nobuaki Egashira,Toshihiro Miyamoto,Eishi Baba,Koichi Akashi,Koichi Takayama,Yoichi Nakanishi,Eriko Tokunaga,Tatsuro Okamoto,Yoshihiko Maehara,Akira Yokomizo,Seiji Naito,Makoto Kubo,Masao Tanaka,Satohiro Masuda
标识
DOI:10.1177/1060028014539919
摘要
Our results support more frequent monitoring of serum calcium concentrations at baseline and during the first 2 weeks of treatment in patients receiving denosumab, especially those with an eGFR <30 mL/min.
科研通智能强力驱动
Strongly Powered by AbleSci AI